Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Lung Cancer Diagnostics Market


6. Market Share Analysis

6.1 Diagnosis Test Type
6.2 Lung cancer Type

6.2.1 Non-Small-cell Lung Cancer Diagnostics Types

6.3 End-User
6.4 Regions


7. Diagnosis Test Type – Global Lung Cancer Diagnostics Market

7.1 Imaging Test
7.2 Biopsy
7.3 Sputum Cytology
7.4 Molecular Test
7.5 Others


8. Lung Cancer Type – Global Lung Cancer Diagnostics Market

8.1 Small-cell Lung Cancer Diagnostics
8.2 Non-Small-cell Lung Cancer Diagnostics

8.2.1 Adenocarcinoma
8.2.2 Squamous Cell Carcinoma
8.2.3 Large cell carcinoma
8.2.4 Others and not otherwise specified


9. End-User – Global Lung Cancer Diagnostics Market

9.1 Hospitals & Clinics
9.2 Diagnostic Centers
9.3 Research Institute
9.4 Others


10. Regions – Global Lung Cancer Diagnostics Market

10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 ROW


11. Company Analysis

11.1 llumina, Inc..

11.1.1 Overviews
11.1.2 Recent Developments
11.1.3 Revenues

11.2 Abbott Laboratories

11.2.1 Overviews
11.2.2 Recent Developments
11.2.3 Revenues

11.3 Thermo Fisher Scientific, Inc

11.3.1 Overviews
11.3.2 Recent Developments
11.3.3 Revenues

11.4 QIAGEN N.V.

11.4.1 Overviews
11.4.2 Recent Developments
11.4.3 Revenues

11.5 Roche Holding AG.

11.5.1 Overviews
11.5.2 Recent Developments
11.5.3 Revenues



List of Figures

Figure-01: Global Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-02: Forecast for – Global Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-03: Diagnosis Test Type – Imaging Test Market (Million US$), 2016 – 2021
Figure-04: Diagnosis Test Type – Forecast for Imaging Test Market (Million US$), 2022 – 2027
Figure-05: Diagnosis Test Type – Biopsy Market (Million US$), 2016 – 2021
Figure-06: Diagnosis Test Type – Forecast for Biopsy Market (Million US$), 2022 – 2027
Figure-07: Diagnosis Test Type –Sputum Cytology Market (Million US$), 2016 – 2021
Figure-08: Diagnosis Test Type – Forecast for Sputum Cytology Market (Million US$), 2022 – 2027
Figure-09: Diagnosis Test Type – Molecular Test Market (Million US$), 2016 – 2021
Figure-10: Diagnosis Test Type – Forecast for Molecular Test Market (Million US$), 2022 – 2027
Figure-11: Diagnosis Test Type – Others Market (Million US$), 2016 – 2021
Figure-12: Diagnosis Test Type – Forecast for Others Market (Million US$), 2022 – 2027
Figure-13: Product – Small-cell Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-14: Product – Forecast for Small-cell Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-15: Product – Non-Small-cell Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-16: Product – Forecast for Non-Small-cell Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-17: Product – Adenocarcinoma Market (Million US$), 2016 – 2021
Figure-18: Product – Forecast for Adenocarcinoma Market (Million US$), 2022 – 2027
Figure-19: Product – Squamous Cell Carcinoma Market (Million US$), 2016 – 2021
Figure-20: Product – Forecast for Squamous Cell Carcinoma Market (Million US$), 2022 – 2027
Figure-21: Product – Large Cell Carcinoma Market (Million US$), 2016 – 2021
Figure-22: Product – Forecast for Large Cell Carcinoma Market (Million US$), 2022 – 2027
Figure-23: Product – Others and not Otherwise Specified Market (Million US$), 2016 – 2021
Figure-24: Product – Forecast for Others and not Otherwise Specified Market (Million US$), 2022 – 2027
Figure-25: End-User – Hospitals & Clinics Market (Million US$), 2016 – 2021
Figure-26: End-User – Forecast for Hospitals & Clinics Market (Million US$), 2022 – 2027
Figure-27: End-User – Diagnostic Centers Market (Million US$), 2016 – 2021
Figure-28: End-User – Forecast for Diagnostic Centers Market (Million US$), 2022 – 2027
Figure-29: End-User – Research Institute Market (Million US$), 2016 – 2021
Figure-30: End-User – Forecast for Research Institute Market (Million US$), 2022 – 2027
Figure-31: End-User – Others Market (Million US$), 2016 – 2021
Figure-32: End-User – Forecast for Others Market (Million US$), 2022 – 2027
Figure-33: North America – Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-34: North America – Forecast for Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-35: Europe – Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-36: Europe – Forecast for Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-37: Asia Pacific – Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-38: Asia Pacific – Forecast for Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-39: Rest of World – Lung Cancer Diagnostics Market (Million US$), 2016 – 2021
Figure-40: Rest of World – Forecast for Lung Cancer Diagnostics Market (Million US$), 2022 – 2027
Figure-41: llumina, Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-42: llumina, Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: Abbott Laboratories – Global Revenue (Million US$), 2016 – 2021
Figure-44: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-45: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2016 – 2021
Figure-46: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-47: QIAGEN N.V. – Global Revenue (Million US$), 2016 – 2021
Figure-48: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-49: Roche Holding AG. – Global Revenue (Million US$), 2016 – 2021
Figure-50: Roche Holding AG. – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2022 – 2027
Table-03: Global –Market Share by Lung Cancer Type (Percent), 2016 – 2021
Table-04: Global – Forecast for Market Share by Lung Cancer Type (Percent), 2022 – 2027
Table-05: Global – Market Share by Non-Small-cell Lung Cancer Diagnostics Types (Percent), 2016 – 2021
Table-06: Global – Forecast for Market Share by Non-Small-cell Lung Cancer Diagnostics Types (Percent), 2022 – 2027
Table-07: Global – Lung Cancer Diagnostics Market Share by End-User (Percent), 2016 – 2021
Table-08: Global – Forecast for Lung Cancer Diagnostics Market Share by End-User (Percent), 2022 – 2027
Table-09: Global – Lung Cancer Diagnostics Market Share by Region (Percent), 2016 – 2021
Table-10: Global – Forecast for Lung Cancer Diagnostics Market Share by Region (Percent), 2022 – 2027